A Comparative Cross-Sectional Study of Cardiac Autonomic Status by Five Minute Heart Rate Variability among Type 2 Diabetics, Hypertensives and Normotensive-Nondiabetics https://doi.org/10.60787/NMJ-64-3-204

Main Article Content

Jayesh D Solanki
Chetna N Hirani
Adnan S Vohra
Sunil J Panjwani
Vatsal M Senta
Darshit K Rudani

Keywords

autonomic neuropathy, blood pressure, cardiac, glycaemic, hypertension, type 2 diabetes

Abstract

Background: Diabetes and hypertension are known to co-exist frequently as adverse cardiovascular risk factors. Both can produce cardiac autonomic neuropathy that can be measured by ECG RR interval-based heart rate variability (HRV). We compared 5 minutes of HRV in four groups based on diabetes and hypertension.


Methodology: A cross-sectional study was done on 203 participants divided into four groups- diabetics, hypertensives, diabetic-hypertensives and normotensive-nondiabetics. They were evaluated for current disease control and five minutes of HRV was done in supine condition following standard protocols by Variowin HR Software. HRV parameters of time domain, frequency domain and Poincare plot were compared between groups and associated with gender, glycaemic control and blood pressure control. Statistical significance was set at p<0.05.


Results: Three diseased groups had mean age in the mid-fifties, mean duration of disease > 6 years, comparable BMI, poor glycaemic and blood pressure control. As compared to normal groups, three diseased groups exhibit reduced HRV with respect to all three domains of HRV with varying statistical significance. Among diseased groups, HRV was associated with blood pressure control better than glycaemic control but not with gender. LF /HF ratio was the most consistent HRV parameter showing statistical significance in tests.


Conclusion: HRV is reduced in both diabetics more than hypertensives; related to blood pressure control more than glycaemic control. It points to altered cardiac autonomic balance and the possibility of cardiovascular risk and early detection of it with timely intervention. It also calls for investigation of the same for reinforcement of our observations and further exploration.

Abstract 535 | PDF Downloads 294

References

1.Thankappan KR, Daivadanam M, Mini GK, Joshi R, Sathish T. Awareness, Treatment, and Control of Hypertension or Diabetes in India: The Impact of Public Health Promotion. Front Public Health. 2022:1244.

2.Solanki JD, Makwana AH, Mehta HB, Gokhale PA, Shah CJ. Hypertension in type 2 diabetes mellitus: Effect of the disease and treatment on development of peripheral artery disease. Int J Diabetes Dev Ctries.2015; 35:380-4.

3.Chowdhury M, Nevitt S, Eleftheriadou A, Kanagala P, Esa H, Cuthbertson DJ, et al. Cardiac autonomic neuropathy and risk of cardiovascular disease and mortality in type 1 and type 2 diabetes: a meta-analysis. BMJ Open Diabetes Res Care.2021;9:e002480.

4.Pham T, Lau ZJ, Chen SH, Makowski D. Heart rate variability in psychology: a review of HRV indices and an analysis tutorial. Sensors.2021;21:3998.

5.Hoshi RA, Santos IS, Dantas EM, Andreão RV, Mill JG, Lotufo PA,et al. Reduced heart-rate variability and increased risk of hypertension—A prospective study of the ELSA-Brasil. J Hum Hypertens. 2021;35:1088-97.

6.Duque A, Mediano MF, De Lorenzo A, Rodrigues Jr LF. Cardiovascular autonomic neuropathy in diabetes: Pathophysiology, clinical assessment and implications. World J Diabetes. 2021;12:855-67.

7.Solanki JD, Basida SD, Mehta HB, Panjwani SJ, Gadhavi BP, Patel P. Impact of disease control and co-existing risk factors on heart rate variability in Gujarati type 2 diabetics: An observational study. J Family Med Prim Care. 2016;5:393-8.

8.Solanki JD, Basida SD, Mehta HB, Panjwani SJ, GadhaviBP. Comparative study of cardiac autonomic status by heart rate variability between under-treatment normotensive and hypertensive known type 2 diabetics. Indian Heart J. 2017;69:52-6.

9.Verma S, Bhati P, Ahmad I, Masroor S, Ali K, Singla D, et al. Co-Existence of hypertension worsens post-exercise cardiac autonomic recovery in type 2 diabetes. Indian Heart J.2018;70(Suppl 3): S82-S89.

10.Mejía-Mejía E, May JM, Torres R, Kyriacou PA. Pulse rate variability in cardiovascular health: A review on its applications and relationship with heart rate variability. Physiol Meas.2020;41:07TR01.

11.Martinez PF, Okoshi MP. Heart rate variability in coexisting diabetes and hypertension. Arq Bras Cardiol.2018;111:73-4.

12.Hoshi RA, Santos IS, Dantas EM, Andreão RV, Schmidt MI, Duncan BB, et al. Decreased heart rate variability as a predictor for diabetes—A prospective study of the Brazilian longitudinal study of adult health. Diabetes Metab Res Rev. 2019;35:e3175.

13.De Barros JA, Macartney MJ, Peoples GE, Notley SR, Herry CL, Kenny GP. The impact of age, type 2 diabetes and hypertension on heart rate variability during rest and exercise at increasing levels of heat stress. Eur J Appl Physiol. 2022;122:1249-59.

14.Tsubokawa M, Nishimura M, Tamada Y, Nakaji S. Factors Associated with Reduced Heart Rate Variability in the General Japanese Population: The Iwaki Cross-Sectional Research Study. Healthcare.2022; 10:793,

15.Garavaglia L, Gulich D, Defeo MM, Thomas Mailland J, Irurzun IM. The effect of age on the heart rate variability of healthy subjects. PLoS One. 2021;16:e0255894.

16.Rajendran R, Sharma VK, Vinod KV, Ananthakrishnan R, Nandeesha H, Subramanian SK. Comparison of cardiac autonomic function across complete glycaemic spectrum. J Basic Clin Physiol Pharmacol. 2022: 0053.

17.Alansare AB, Bates LC, Stoner L, Kline CE, Nagle E, Jennings JR, et al. Associations of sedentary time with heart rate and heart rate variability in adults: a systematic review and meta-analysis of observational studies. Int J Environ Res Public Health. 2021; 18:8508.

18.Solanki JD, Sheth NS, Shah CJ, Mehta HB. Knowledge, attitude, and practice of urban Gujarati type 2 diabetics: Prevalence and impact on disease control. J Educ Health Promot.2017; 6:35.

19.VinikA, Maser R, Ziegler D. Autonomic Imbalance: Prophet of Doom or Scope for Hope? Diabet Med.2011; 28:643–51.

20.Wu JS, Yang YC, Lin TS, Huang YH, Chen JJ, Lu FH, et al. Epidemiological evidence of altered cardiac autonomic function in subjects with impaired glucose tolerance but not isolated impaired fasting glucose. J Clin Endocrinol Metab.2007; 92:3885–9.

21.Maciorowska M, Krzesiński P, Wierzbowski R, Uziębło-Życzkowska B, GielerakG. Associations between Heart Rate Variability Parameters and Hemodynamic Profiles in Patients with Primary Arterial Hypertension, Including Antihypertensive Treatment Effects. J Clin Med.2022;11:3767.

22.Eleftheriadou A, Williams S, Nevitt S, Brown E, Roylance R, Wilding JP, et al. The prevalence of cardiac autonomic neuropathy in prediabetes: a systematic review. Diabetologia.2021;64:288-303.

23.Martinez M, Santamarina J, Pavesi A, Musso C, Umpierrez GE. Glycemic variability and cardiovascular disease in patients with type 2 diabetes. BMJ Open Diabetes Res Care.2021;9: e002032.

24.Hoshi RA, Santos IS, Dantas EM, Andreão RV, Mill JG, Lotufo PA,et al. Reduced heart-rate variability and increased risk of hypertension—A prospective study of the ELSA-Brasil. J Hum Hypertens.2021;35:1088-97.

25.Parati G, Torlasco C, PengoM, Bilo G, Ochoa JE. Blood pressure variability: its relevance for cardiovascular homeostasis and cardiovascular diseases. Hypertens Res.2020;43:609-20.

26.Kleiger RE, Stein PK, Bigger JT. Heart rate variability: measurement and clinical utility. Ann Noninvasive Electrocardiol.2005;10:88-101.

27.Forte G, Morelli M, Casagrande M. Heart rate variability and decision-making: Autonomic responses in making decisions. Brain Sci.2021;11:243.

28.Fournié C, Chouchou F, Dalleau G, Caderby T, Cabrera Q, VerkindtC. Heart rate variability biofeedback in chronic disease management: A systematic review. Complement Ther Med.2021;60:102750.

29.Wehler D, Jelinek HF, Gronau A, Wessel N, Kraemer JF, Krones R, et al. Reliability of heart-rate-variability features derived from ultra-short ECG recordings and their validity in the assessment of cardiac autonomic neuropathy. Biomed Signal Process Control.2021;68:102651.